drugset / Trial / NCT05537883

Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients

NCT05537883

Phase 1 Completed 72 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate if laparoscopic Transversus Abdominis Plane (TAP) block using plain bupivacaine is equivalent to using liposomal bupivacaine in patients undergoing metabolic and bariatric surgery. The study will see if the plain bupivacaine group will be equivalent in terms of length of stay, Morphine Milligram Equivalents, Pain scores and patient satisfaction, but cost less.

Timeline

Start
2022-11-29
Primary completion
2023-12-07
Completion
2023-12-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other
Comparator Bupivacaine Other / unclassified 50 ml Other

Indications